Instalab
logoInstalab

Enteropathogenic E. Coli

Stool Test
Find out whether a culture-missed gut bacterium is part of the story behind watery diarrhea.
4.9 (4,788 reviews)
Tested by US Biotek Laboratories
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Self-collect at home
Kit shipped directly to you
Get results
Explained with clear next steps, no medical jargon

Should you take a Enteropathogenic E. Coli test?

This test is most useful if any of these apply to you.

Dealing With Diarrhea That Won't Quit
When loose stools have run for weeks, this can find a pathogen routine stool culture usually misses.
Sick Since You Got Back From a Trip
Travel-related diarrhea often involves several organisms, and this is commonly found on broad panels.
On Chemo or Immune-Suppressing Drugs
A positive carries more weight when your defenses are down and diarrhea can delay treatment.
Told It Might Be Inflammatory Bowel Disease
Ruling infection in or out is part of the workup before symptoms get pinned on bowel inflammation.

About Enteropathogenic E. Coli

Routine stool culture alone usually won't identify this pathotype. The E. coli colonies that cause it can look like the harmless E. coli in everyone's colon, so growing colonies on a plate is not enough to tell them apart. This test reads pathogen genes in stool, which is why it can find strains routine culture misses.

The catch is the mirror image of that strength. A positive result tells you the organism's DNA is in your stool. It does not prove the organism is making you sick, and in a large African study of children, the atypical form turned up slightly more often in healthy kids than in kids with severe diarrhea. Reading your own result well means understanding both halves of that.

What the Test Actually Looks For

EPEC is a diarrhea-associated pathotype of E. coli. A pathotype is a strain grouped by the genes that make it behave a certain way. This is a pathogen finding in stool, not a body level you raise or lower.

PCR is the gene-reading method used by these panels. Most clinical panels identify EPEC by looking for a gene called eae, while also checking that Shiga toxin genes are absent. The eae gene builds intimin, a protein the bacterium uses to grip the intestinal lining, flatten tiny absorptive hairs on the surface, and rearrange the cell's internal scaffolding underneath itself. That gripping damage is how it can cause watery stool.

Many panels report detected or not detected. Some research and specialty assays estimate amount, but even those are still reading DNA. They are not proving that every organism detected is alive.

There is a second gene worth knowing about, though most commercial panels do not check for it. Typical EPEC carries bfpA, which builds bundled fibers that let the bacteria clump together and stick more aggressively. Atypical EPEC lacks it. Atypical strains are often the more common kind now, and they are also the more ambiguous kind, ranging from silent carriage to outbreaks and prolonged illness.

Watery Diarrhea, Especially in Small Children

The clearest disease link is watery diarrhea in infants and young children. This is where EPEC earned its name and where the evidence is strongest. In a Peruvian study using quantitative testing, children with diarrhea carried roughly ten times more EPEC per milligram of stool than healthy children did: 299 versus 29 bacteria per milligram.

It is also linked to diarrhea that drags on. Australian children with atypical EPEC had mild symptoms but prolonged illness, and Mexican children with atypical strains had acute episodes lasting seven to twelve days. In lower-income settings, repeated detection has been tied to gut inflammation and slower growth.

What this means for you: if you are an adult with a few days of watery stool and an isolated positive, the bacterium is a plausible but unproven explanation. If diarrhea has run for weeks, the finding carries more weight, and it also raises the question of whether something else is driving your symptoms.

When a Positive Means Very Little

Here is the finding that should reset how you read your own result. In the VIDA study, which compared thousands of young children with moderate-to-severe diarrhea against matched healthy controls in three African countries, atypical EPEC showed up in 27.3% of the healthy controls and 23.3% of the diarrhea cases. More common in the well children. Neither typical nor atypical strains were significantly associated with the illness.

Adult data point the same direction. Among hospitalized patients in Norway whose only positive finding was EPEC, 73% had a documented non-infectious cause for their diarrhea, such as tube feeding or laxatives. A separate study of 792 symptomatic patients found no statistically significant difference in adult hospital stay between EPEC-positive patients and matched patients whose stool panels were negative.

Carriage explains why. EPEC is found in 3% to 20% of asymptomatic people in several studies. In one Norwegian study of 1,000 asymptomatic people, atypical EPEC was found in 16% overall and was much more common in the youngest children. A sensitive test applied to an organism this common will find it in plenty of people whose gut symptoms have another cause.

Reconciling the Two Halves

So which is it, real pathogen or harmless passenger? Both. This is not a good-number-bad-number marker. It is a presence marker for an organism whose behavior depends on the strain, the amount, and the host.

High bacterial loads track with symptoms better than a simple positive result does. Typical strains behave more consistently like pathogens than atypical ones. A child in a high-transmission setting, an adult on chemotherapy, and a healthy traveler carrying the same genes are three different clinical situations. The positive is the start of the reasoning, not the end of it.

Immune Suppression Changes the Calculus

The group where a positive carries more weight is people whose immune defenses are down. In a study of cancer and immunosuppressed patients with EPEC-associated diarrhea, the organism was present at higher burden, resistance to common antibiotics was common, and the illness delayed cancer care in a subset of patients. If you are on chemotherapy, on immunosuppressive drugs after a transplant, or have advanced immune suppression, a positive deserves a different response than it would in a healthy adult.

This Is Not the E. coli That Causes Kidney Failure

Plenty of people see E. coli on a lab report and think of O157 outbreaks, bloody diarrhea, and hemolytic uremic syndrome, the kidney complication that can follow Shiga toxin infection. Classic EPEC is defined by the absence of Shiga toxin genes. That is what separates it from STEC, the Shiga toxin-producing strain group linked to that complication.

The two can share the eae gene, which is the main source of laboratory confusion between them. A panel that calls EPEC is usually calling eae-positive, Shiga-toxin-negative. If your panel tested toxin genes and they were negative, that kidney complication is not the expected concern from this result. Bloody stool still changes the situation and deserves prompt evaluation.

How Long It Stays Detectable

Acute atypical EPEC illness in a U.S. case-control study was usually mild and lasted about six to thirteen days. Some people had persistent or chronic diarrhea, and some people stayed colonized for months to years or appeared to be infected again.

PCR can also stay positive after symptoms improve. The test reads DNA, and DNA does not always mean live bacteria causing current illness. In a 2026 multicenter study of adults who repeated gastrointestinal PCR panels within 14 days, 51% of initially positive patients still had at least one original pathogen detected. New findings that warranted antibiotics were rare.

That is why retesting to prove you are cured is usually a bad use of the test. A lingering positive may be colonization, leftover DNA, or the tail of the same episode.

Why a Single Reading Can Fool You

Four things distort a result often enough to matter:

  • Carriage from a past infection: DNA from an infection you already cleared can linger. A positive after your symptoms have resolved may not be a current problem.
  • Gene overlap with STEC: the eae gene is not unique to EPEC. If Shiga toxin testing is incomplete, a toxin-producing strain can be confused with an EPEC-like result.
  • Laxatives, tube feeding, and other non-infectious causes: these can produce diarrhea that prompts testing, which then finds whatever bacteria happen to be present. In one hospital audit, a large share of panel orders were placed outside recommended criteria, including after laxative use.
  • Sample problems: very thick specimens, visible blood, or delayed handling can interfere with PCR. Many labs catch this as an invalid result and ask for a new sample, but poor samples can still make results less reliable.

What to Do With an Out-of-Pattern Result

Start with the shape of your whole panel, not the single line. EPEC is often found alongside something else. In a multicenter stool PCR panel study, a large share of EPEC detections came alongside at least one other organism, and pediatric traveler's diarrhea studies found mixed infections even more often. When another established pathogen is on the same report, such as Campylobacter, norovirus, Giardia, or C. difficile, that organism may explain more of the illness.

If EPEC is the only thing detected and your symptoms are mild and improving, look away from the bacterium and at everything else. Recent antibiotics, laxatives, a new medication, tube feeds, or a major change in diet explain many isolated positives.

If symptoms have persisted for weeks, the pathway widens. Stool microscopy or parasite PCR covers organisms some bacterial panels skip. Fecal calprotectin can show whether the bowel is inflamed, though it does not by itself prove inflammatory bowel disease. Ongoing diarrhea with weight loss, bleeding, fever, dehydration, or abnormal inflammatory markers is a good reason to involve a gastroenterologist.

Two situations warrant faster escalation. Bloody diarrhea should be evaluated promptly, because STEC, Shigella, Salmonella, and Campylobacter become more important possibilities. And if you are immunosuppressed, a positive should go to your treating physician rather than being watched. If antibiotics are being considered, culture is needed to grow the organism and test which drugs still work. PCR cannot do that.

Retesting and Tracking

This is not a number you trend. It is a presence-or-absence result tied to a specific episode of illness, and the right cadence is to test when you have symptoms worth explaining, not on a schedule. Repeating the panel to confirm clearance often misleads, because residual DNA can keep the result positive after you feel well.

What is worth tracking is the pattern across episodes. If you have recurrent bouts of diarrhea over months, keep a record of which organisms appeared each time, which did not, and what was happening around each episode. Repeated detection across separate illnesses with clear well periods in between tells a different story than a single hit.

Frequently Asked Questions

References

25 studies
  1. J. B. Ochieng, H. Powell, Ciara E. Sugerman, R. Omore, B. Ogwel, J. Juma, a. Awuor, S. Sow, D. Sanogo, U. Onwuchekwa, a. M. Keita, a. Traoré, H. Badji, M. J. Hossain, J. C. Jones, I. Kasumba, Dilruba Nasrin, Anna Roose, Yuan-yuan Liang, Leslie P. Jamka, M. Antonio, J. Platts-mills, Jie Liu, E. Houpt, E. Mintz, E. Hunsperger, C. Onyango, N. Strockbine, M. a. Widdowson, J. Verani, S. Tennant, K. KotloffClinical Infectious Diseases2023
  2. Sarah E. Kralicek, Lalitha M. Sitaraman, Paulius V. Kuprys, a. Harrington, Bharat Ramakrishna, M. Osman, G. HechtGastroenterology2022
  3. E. Bizot, S. Bonacorsi, P. Labé, Y. Pinhas, a. Cointe, Agnès Ferroni, Jérémie F. Cohen, Hervé Lécuyer, J. ToubianaJournal of Clinical Microbiology2025
  4. A. Olvera, Hannah E. Carter, Anubama Rajan, L. Carlin, Xiao-min Yu, Xi-lei Zeng, S. Shelburne, Micah M. Bhatti, S. Blutt, N. Shroyer, R. Jenq, M. Estes, a. Maresso, P. OkhuysenClinical Infectious Diseases2020